Impeto Medical - About the company
Impeto Medical is an acquired company based in Paris (France), founded in 2005. It operates as a Diabetes detection & diabetes testing equipment. Impeto Medical has raised $6.8M in funding. The company has 11 active competitors, including 1 that has exited. Its top competitors include companies like NephroCheck, VibroSense and Ceeable.
Company Details
Impeto Medical SAS is a privately owned medical device company. It manufactures and markets devices for non-invasive assessment of eccrine sweat gland activity through Sudorimetry. SUDOSCAN is a FDA cleared device. Other products for diabetes detection and diabetes testing include EZSCAN and SUDOSCAN+, and are approved in regions outside the US. Its corporate headquarters are located in Paris, France. Two subsidiaries have been created: Beijing Impeto Medical in China and Impeto Medical Inc. in San Diego, U.S.
- Website
- impeto-medical.com
- Social
- Registered Address
- 17, Rue Campagne Première Paris, 75014 France
Key Metrics
Founded Year
2005
Location
Paris, France
Stage
Acquired
Total Funding
$6.8M in 2 rounds
Latest Funding Round
Investors
Ranked
1st among 11 active competitors
Employee Count
27 as on Jul 01, 2024
Similar Companies
Exit Details
Acquired by Withings (Jan 11, 2022)
Legal entities associated with Impeto Medical
Impeto Medical is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Impeto Medical SAS CIN: FR482837366 , France, Active | Jun 21, 2005 | - | - | - |
Impeto Medical's acquisition details
Impeto Medical got acquired by Withings on Jan 11, 2022.
Click here to take a look at Impeto Medical's acquisition in detail
Sign up to download Impeto Medical's company profile
Impeto Medical's funding and investors
Impeto Medical has raised a total funding of $6.8M over 2 rounds. Its first funding round was on Jan 31, 2011. Its latest funding round was a Venture Debt round on Dec 2016 for $*****. 1 investor participated in its latest round. Impeto Medical has 3 institutional investors.
Here is the list of recent funding rounds of Impeto Medical:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 2016 | 2107742 | Venture Debt | 9576262 | 8321491 | 8082818 | 7709206 |
Jan 31, 2011 | 8222765 | Series B | 9088428 | 1065775 | 4989164 | 4536455 |
Access funding benchmarks and valuations. Sign up today!View details of Impeto Medical's funding rounds and investors
Impeto Medical's founders and board of directors
Founder? Claim ProfileImpeto Medical's employee count trend
Impeto Medical has 27 employees as of Jul 24. Here is Impeto Medical's employee count trend over the years:
Uncover Impeto Medical's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Impeto Medical's Competitors and alternates
Top competitors of Impeto Medical include NephroCheck, VibroSense and Ceeable. Here is the list of Top 10 competitors of Impeto Medical, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Impeto Medical 2005, Paris (France), Acquired | Diabetes detection & diabetes testing equipment | $6.8M | 42/100 | |
2nd | NephroCheck 2011, San Diego (United States), Unfunded | Diagnostics company dedicated to improving health through innovative diagnostic solutions | - | - | 30/100 |
3rd | VibroSense 2005, Malmo (Sweden), Funding Raised | Develops solutions for early detection and diagnosis of peripheral sensory neuropathy | - | 29/100 | |
4th | _1527137377556.png?devicePixelRatio=2&height=30&width=30){kind=logo} Ceeable 2014, Somerville (United States), Funding Raised | Tablet-based visual field analyzer technology | - | 29/100 | |
5th |  Susdoscan 2011, San Diego (United States), Unfunded | Innovative medical device for early detection of autonomic and small fiber neuropathy | - | - | 27/100 |
6th | Provider of genetic testing for diabetes management | - | - | 25/100 | |
7th | _1560416076155.png?devicePixelRatio=2&height=30&width=30){kind=logo} RetinaScan 2017, Guildford (United Kingdom), Unfunded | Developer of artificial intelligence based medical image analysis platform | - | - | 24/100 |
8th | NephroSense 2014, Denver (United States), Unfunded | Provider of point-of-care diagnostic device for kidney function monitoring | - | - | 24/100 |
9th | Omics Global Solutions 2016, San Juan (Puerto Rico), Unfunded | ELISA assay for the prognosis of diabetic Kidney disease | - | - | 22/100 |
10th | Diabetica Solutions 1996, San Antonio (United States), Deadpooled | Diagnostic solutions for early detection of diabetes-related complications | $2.4M | 20/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Impeto Medical's competitors? Click here to see the top ones
Impeto Medical's Investments and acquisitions
Impeto Medical has made no investments or acquisitions yet.
News related to Impeto Medical
•
Withings Vital Biometrics IP Acquisition Reflects Medical-Consumer Fitness ConvergenceFindBiometrics•Jan 13, 2022•Withings, Impeto Medical
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Impeto Medical
Explore our recently published companies
- Jumo - India based, Unfunded company
- APL - Wednesbury based, 2022 founded, Funding Raised company
- Boston HealthNet (BHN) Research Collaborative - United States based, 2021 founded, Funding Raised company
- PS Digital - Chicago based, 2025 founded, Unfunded company
- Innovation Investment Capital - Cardiff based, 2022 founded, Unfunded company
- North Staffs Tyre & Battery - Newcastle-under-lyme based, 2021 founded, Acquired company
